And some data bellow ⬇️ (1/10)
📄 In this before/after study, we evaluated the impact of an AMS intervention in patients with high-risk febrile neutropenia. The guidelines were based on a discontinuation/de-escalation strategy based on ECIL4 recommendations. (2/10)